Glynase PresTab is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Glynase PresTab is considered an adjunct treatment to diet and exercise. Glynase PresTab is also referred to by its drug name, Glyburide.
Glynase PresTab is a sulfonylurea. Glynase PresTab is believed to work by increasing the amount of insulin released by the pancreas.
How do I take it?
Prescribing information states that Glynase PresTab is generally taken once daily, in the morning with breakfast.
Glynase PresTab comes in tablet form.
The FDA-approved label for Glynase PresTab lists common side effects including hypoglycemia (low blood sugar), nausea, heartburn, full-stomach sensation, joint or muscle pain, blurry vision, rash, and itching.
Rare but serious side effects listed for Glynase PresTab include jaundice and systemic allergic reaction.
We never share your personal information with anyone.